BASSLER BONNIE L sold 46.8% of their position (1.50K shares) of REGENERON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.20M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/8/2026ACC: 0001683607-26-000008
Director
Since Jan 2019
-1.50K
Net shares
Net seller
$1.20M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.50K acquired · 3K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.50K
Price / share
$374.12
Trade value
$561.18K
% of position
88.1%
1/7/2026
1.70K→3.20K
Common Stock
Direct
Shares
−1.50K
Price / share
$800.00
Trade value
$1.20M
% of position
46.8%
1/7/2026
3.20K→1.70K
Total
Net shares
+0.00
Net value
-$638.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2026 | M · Option Exercise | +1.50K | $374.12 | $561.18K | 88.1% | 1.70K | 3.20K |
| Common Stock Direct | 1/7/2026 | S · Sale | −1.50K | $800.00 | $1.20M | 46.8% | 3.20K | 1.70K |
| Total | +0.00 | -$638.82K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
1.50K shares
Shares
−1.50K
Strike price
374.12
Held after
2.86K
Exercisable
—
1/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1.50K shares | 1/7/2026 | M · Option Exercise | −1.50K | 374.12 | — | 2.86K |